Literature DB >> 19000821

Small-molecule CD4 mimics interact with a highly conserved pocket on HIV-1 gp120.

Navid Madani1, Arne Schön, Amy M Princiotto, Judith M Lalonde, Joel R Courter, Takahiro Soeta, Danny Ng, Liping Wang, Evan T Brower, Shi-Hua Xiang, Young Do Kwon, Chih-Chin Huang, Richard Wyatt, Peter D Kwong, Ernesto Freire, Amos B Smith, Joseph Sodroski.   

Abstract

Human immunodeficiency virus (HIV-1) interaction with the primary receptor, CD4, induces conformational changes in the viral envelope glycoproteins that allow binding to the CCR5 second receptor and virus entry into the host cell. The small molecule NBD-556 mimics CD4 by binding the gp120 exterior envelope glycoprotein, moderately inhibiting virus entry into CD4-expressing target cells and enhancing CCR5 binding and virus entry into CCR5-expressing cells lacking CD4. Studies of NBD-556 analogs and gp120 mutants suggest that (1) NBD-556 binds within the Phe 43 cavity, a highly conserved, functionally important pocket formed as gp120 assumes the CD4-bound conformation; (2) the NBD-556 phenyl ring projects into the Phe 43 cavity; (3) enhancement of CD4-independent infection by NBD-556 requires the induction of conformational changes in gp120; and (4) increased affinity of NBD-556 analogs for gp120 improves antiviral potency during infection of CD4-expressing cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19000821      PMCID: PMC2597202          DOI: 10.1016/j.str.2008.09.005

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  38 in total

1.  Ligand binding characteristics of CXCR4 incorporated into paramagnetic proteoliposomes.

Authors:  G J Babcock; T Mirzabekov; W Wojtowicz; J Sodroski
Journal:  J Biol Chem       Date:  2001-08-06       Impact factor: 5.157

2.  Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening.

Authors:  Thomas A Halgren; Robert B Murphy; Richard A Friesner; Hege S Beard; Leah L Frye; W Thomas Pollard; Jay L Banks
Journal:  J Med Chem       Date:  2004-03-25       Impact factor: 7.446

3.  Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy.

Authors:  Richard A Friesner; Jay L Banks; Robert B Murphy; Thomas A Halgren; Jasna J Klicic; Daniel T Mainz; Matthew P Repasky; Eric H Knoll; Mee Shelley; Jason K Perry; David E Shaw; Perry Francis; Peter S Shenkin
Journal:  J Med Chem       Date:  2004-03-25       Impact factor: 7.446

4.  Rational engineering of a miniprotein that reproduces the core of the CD4 site interacting with HIV-1 envelope glycoprotein.

Authors:  C Vita; E Drakopoulou; J Vizzavona; S Rochette; L Martin; A Ménez; C Roumestand; Y S Yang; L Ylisastigui; A Benjouad; J C Gluckman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

5.  Identification of N-phenyl-N'-(2,2,6,6-tetramethyl-piperidin-4-yl)-oxalamides as a new class of HIV-1 entry inhibitors that prevent gp120 binding to CD4.

Authors:  Qian Zhao; Liying Ma; Shibo Jiang; Hong Lu; Shuwen Liu; Yuxian He; Nathan Strick; Nouri Neamati; Asim Kumar Debnath
Journal:  Virology       Date:  2005-09-01       Impact factor: 3.616

6.  Structure-based prediction of binding affinities and molecular design of peptide ligands.

Authors:  I Luque; E Freire
Journal:  Methods Enzymol       Date:  1998       Impact factor: 1.600

7.  Characterization of a discontinuous human immunodeficiency virus type 1 gp120 epitope recognized by a broadly reactive neutralizing human monoclonal antibody.

Authors:  M Thali; U Olshevsky; C Furman; D Gabuzda; M Posner; J Sodroski
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

8.  Critical role of Arg59 in the high-affinity gp120-binding region of CD4 for human immunodeficiency virus type 1 infection.

Authors:  Danielle Fontenot; Jason K Jones; Mohammad M Hossain; Pramod N Nehete; Eric M Vela; Victor A Dwyer; K Jagannadha Sastry
Journal:  Virology       Date:  2007-02-23       Impact factor: 3.616

9.  Evidence for CD4-enchanced signaling through the chemokine receptor CCR5.

Authors:  Robert Staudinger; Sanjay K Phogat; Xiaodong Xiao; Xiahong Wang; Dimiter S Dimitrov; Susan Zolla-Pazner
Journal:  J Biol Chem       Date:  2003-01-15       Impact factor: 5.157

10.  Determinants of human immunodeficiency virus type 1 envelope glycoprotein activation by soluble CD4 and monoclonal antibodies.

Authors:  N Sullivan; Y Sun; J Binley; J Lee; C F Barbas; P W Parren; D R Burton; J Sodroski
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

View more
  93 in total

1.  Discovery of entry inhibitors for HIV-1 via a new de novo protein design framework.

Authors:  M L Bellows; M S Taylor; P A Cole; L Shen; R F Siliciano; H K Fung; C A Floudas
Journal:  Biophys J       Date:  2010-11-17       Impact factor: 4.033

2.  Inhibiting early-stage events in HIV-1 replication by small-molecule targeting of the HIV-1 capsid.

Authors:  Sandhya Kortagere; Navid Madani; Marie K Mankowski; Arne Schön; Isaac Zentner; Gokul Swaminathan; Amy Princiotto; Kevin Anthony; Apara Oza; Luz-Jeannette Sierra; Shendra R Passic; Xiaozhao Wang; David M Jones; Eric Stavale; Fred C Krebs; Julio Martín-García; Ernesto Freire; Roger G Ptak; Joseph Sodroski; Simon Cocklin; Amos B Smith
Journal:  J Virol       Date:  2012-05-30       Impact factor: 5.103

3.  Enhanced exposure of human immunodeficiency virus type 1 primary isolate neutralization epitopes through binding of CD4 mimetic compounds.

Authors:  Kazuhisa Yoshimura; Shigeyoshi Harada; Junji Shibata; Makiko Hatada; Yuko Yamada; Chihiro Ochiai; Hirokazu Tamamura; Shuzo Matsushita
Journal:  J Virol       Date:  2010-05-26       Impact factor: 5.103

Review 4.  HIV-1 gp120 as a therapeutic target: navigating a moving labyrinth.

Authors:  Priyamvada Acharya; Sabrina Lusvarghi; Carole A Bewley; Peter D Kwong
Journal:  Expert Opin Ther Targets       Date:  2015-02-27       Impact factor: 6.902

5.  Some binding-related drug properties are dependent on thermodynamic signature.

Authors:  Arne Schön; Navid Madani; Amos B Smith; Judith M Lalonde; Ernesto Freire
Journal:  Chem Biol Drug Des       Date:  2011-02-02       Impact factor: 2.817

6.  A V3 loop-dependent gp120 element disrupted by CD4 binding stabilizes the human immunodeficiency virus envelope glycoprotein trimer.

Authors:  Shi-Hua Xiang; Andrés Finzi; Beatriz Pacheco; Kevin Alexander; Wen Yuan; Carlo Rizzuto; Chih-Chin Huang; Peter D Kwong; Joseph Sodroski
Journal:  J Virol       Date:  2010-01-20       Impact factor: 5.103

7.  Computational identification of novel entry inhibitor scaffolds mimicking primary receptor CD4 of HIV-1 gp120.

Authors:  Alexander M Andrianov; Ivan A Kashyn; Alexander V Tuzikov
Journal:  J Mol Model       Date:  2017-01-03       Impact factor: 1.810

8.  Binding thermodynamics of the N-terminal peptide of the CCR5 coreceptor to HIV-1 envelope glycoprotein gp120.

Authors:  Evan T Brower; Arne Schön; Jeffrey C Klein; Ernesto Freire
Journal:  Biochemistry       Date:  2009-02-03       Impact factor: 3.162

9.  Use of the quartz crystal microbalance to monitor ligand-induced conformational rearrangements in HIV-1 envelope protein gp120.

Authors:  Hyun-Su Lee; Mark Contarino; M Umashankara; Arne Schön; Ernesto Freire; Amos B Smith; Irwin M Chaiken; Lynn S Penn
Journal:  Anal Bioanal Chem       Date:  2009-12-17       Impact factor: 4.142

10.  Identification of a human immunodeficiency virus type 1 envelope glycoprotein variant resistant to cold inactivation.

Authors:  Aemro Kassa; Andrés Finzi; Marie Pancera; Joel R Courter; Amos B Smith; Joseph Sodroski
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.